These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22968078)

  • 21. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
    Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
    Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
    Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
    Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
    [No Abstract]   [Full Text] [Related]  

  • 25. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
    Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD
    Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.
    Shyr BU; Chen SC; Shyr YM; Wang SE
    Surg Endosc; 2020 Jan; 34(1):377-383. PubMed ID: 30963260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of invasion and resection of superior mesenteric and portal veins in adenocarcinoma of the pancreas.
    Aktekin A; Küçük M; Odabaşi M; Muftuoglu T; Gürleyik G; Özkara S; Aker F; Saglam A
    Hepatogastroenterology; 2013; 60(125):1194-8. PubMed ID: 23803382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein resection for ductal adenocarcinoma in the head of the pancreas.
    Landi F; Dopazo C; Sapisochin G; Beisani M; Blanco L; Caralt M; Balsells J; Charco R
    Cir Esp; 2015 Oct; 93(8):522-9. PubMed ID: 25981612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
    Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
    Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome?
    Martin D; Petermann D; Fontanella S; Pu Y; Halkic N; Demartines N; Schäfer M
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1507-1513. PubMed ID: 30222630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
    Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
    J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
    Tran Cao HS; Balachandran A; Wang H; Nogueras-González GM; Bailey CE; Lee JE; Pisters PW; Evans DB; Varadhachary G; Crane CH; Aloia TA; Vauthey JN; Fleming JB; Katz MH
    J Gastrointest Surg; 2014 Feb; 18(2):269-78; discussion 278. PubMed ID: 24129826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
    Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
    Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration.
    Malleo G; Maggino L; Marchegiani G; Feriani G; Esposito A; Landoni L; Casetti L; Paiella S; Baggio E; Lipari G; Capelli P; Scarpa A; Bassi C; Salvia R
    Pancreatology; 2017; 17(5):847-857. PubMed ID: 28843714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
    Michalski CW; Kong B; Jäger C; Kloe S; Beier B; Braren R; Esposito I; Erkan M; Friess H; Kleeff J
    BMC Surg; 2015 Aug; 15():100. PubMed ID: 26296752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
    Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
    J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
    Shimoda M; Mori S; Kita J; Sawada T; Kubota K
    Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head.
    Carrère N; Sauvanet A; Goere D; Kianmanesh R; Vullierme MP; Couvelard A; Ruszniewski P; Belghiti J
    World J Surg; 2006 Aug; 30(8):1526-35. PubMed ID: 16855797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.